Since the introduction of the aldosterone-to-renin ratio (ARR) as a screening test for primary
aldosteronism (PA), there has been a marked increase in the reported prevalence of this …

Recognition that primary aldosteronism (PAL) is a common specifically treatable form of
hypertension and that most patients are normokalemic has led to a marked increase in …

Background: The aldosterone-to-renin ratio (ARR) is a widely used screening test for
primary aldosteronism. Current guidelines recommend a cut-off value of 91 pmol/mU …

The traditional workup for primary aldosteronism is cumbersome and requires discontinuing
antihypertensive medications, which is inconvenient and potentially dangerous. A simple …

Objective. We conducted a systematic review of the literature to establish the test
characteristics (sensitivity, specificity, likelihood ratios at different cutoff values) of the …

Recent reviews recommended the use of the aldosterone/renin ratio (ARR) to screen for
primary hyperaldosteronism. However, widely different cutoff levels have been proposed …

Primary aldosteronism (PA) is a severe and often underdiagnosed form of secondary
hypertension. Determining the aldosterone to renin ratio (ARR) in hypertensive patients has …

Objective To determine whether the calculated ratio of plasma aldosterone concentration
(PAC) to plasma renin activity (PRA), a proposed screening test for primary aldosteronism …

Background The upright serum aldosterone/upright plasma renin activity ratio (ARR) has
been recommended as a screening tool for the diagnosis of primary aldosteronism …

Availability and wider application of the plasma aldosterone/renin ratio (ARR) as a
screening test for primary aldosteronism (PA) has led to the recognition that PA is the most …